Supply of Levonorgestrel and Ethinyl Estradiol Tablets

This subcontract, issued by the Department of Defense Medical Supply Chain Pharm FSA, involves the procurement of Levonorgestrel and Ethinyl Estradiol tablets to support prime contractors delivering DLA supply contracts. The selected provider is responsible for the manufacture or procurement of the pharmaceutical compound, ensuring that all packaging and labeling strictly adhere to the 29 CFR 1910.1200 Hazard Communication Standard and the DLA Master List of Technical and Quality Requirements RA001. The scope of work requires the delivery of 1,000 packages of the pharmaceutical tablets to Fort Campbell. Eligible bidders must maintain an active SAM registration to be considered for this opportunity. The contract falls under NAICS code 325412, with a response deadline set for November 2, 2026. All deliverables must meet the specific technical and quality standards mandated by the agency to ensure pharmaceutical compliance and safety.